Showing results (271-280 of 293) with videos related to

Sort By:
Pageof 30
International Journal of Cancer|December 14, 2017
Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)Stefan Stangl, Nikoletta Tontcheva, Wolfgang Sievert, et al.
The Journal of Molecular Diagnostics : JMD|April 6, 2020
Comparison of GeneChip, nCounter, and Real-Time PCR-Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell CarcinomaStefan Schmidt, Annett Linge, Marianne Grosser, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2023
The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: Robust gene signature correlates with radiotherapy outcome in patients and xenograftsAnnett Linge, Shivaprasad Patil, Marianne Grosser, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 4, 2018
Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCCAnnett Linge, Ulrike Schötz, Steffen Löck, et al.
Cancers|August 12, 2022
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer PatientsJulia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 9, 2022
Analyses of molecular subtypes and their association to mechanisms of radioresistance in patients with HPV-negative HNSCC treated by postoperative radiochemotherapyShivaprasad Patil, Bouchra Tawk, Marianne Grosser, et al.
Neuro-Oncology Practice|May 13, 2024
App-based assessment of patient-reported outcomes in the Molecular Tumor Board in the Center for Personalized Medicine-(TRACE)Lorenz Dörner, Lucia Grosse, Felix Stange, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 2, 2018
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV InfectionJulia Hess, Kristian Unger, Cornelius Maihoefer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2014
Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasetsTomas Skripcak, Claus Belka, Walter Bosch, et al.
The Pharmacogenomics Journal|June 18, 2020
ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapyMaja Guberina, Ali Sak, Christoph Pöttgen, et al.
Pageof 30